Invaio Sciences Acquires Peptyde Bio
December 7, 2023
Invaio Sciences has acquired Peptyde Bio, a Danforth Technology Company spinout that discovers and designs antimicrobial peptides for crop protection. The deal brings Peptyde Bio’s peptide discovery platform and IP into Invaio’s AI-enabled discovery engine and biological delivery systems to accelerate nature-positive crop protection solutions.
- Buyers
- Invaio Sciences
- Targets
- Peptyde Bio
- Sellers
- Danforth Technology Company, Donald Danforth Plant Science Center
- Industry
- Biotechnology
- Location
- Missouri, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.